Melissa A. Kotterman

1.4k total citations · 2 hit papers
9 papers, 1.1k citations indexed

About

Melissa A. Kotterman is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Melissa A. Kotterman has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in Melissa A. Kotterman's work include Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (5 papers) and RNA Interference and Gene Delivery (4 papers). Melissa A. Kotterman is often cited by papers focused on Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (5 papers) and RNA Interference and Gene Delivery (4 papers). Melissa A. Kotterman collaborates with scholars based in United States and South Korea. Melissa A. Kotterman's co-authors include David V. Schaffer, Thomas W. Chalberg, Jennifer M. Strazzeri, William H. Merigan, Lu Yin, John G. Flannery, Tandis Vazin, Peter J. Francis, Roxanne H. Croze and David H. Kirn and has published in prestigious journals such as Nature Reviews Genetics, Development and European Heart Journal.

In The Last Decade

Melissa A. Kotterman

9 papers receiving 1.1k citations

Hit Papers

Engineering adeno-associated viruses for clinical gene th... 2014 2026 2018 2022 2014 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa A. Kotterman United States 5 935 607 119 89 82 9 1.1k
Lars Aagaard Denmark 20 2.1k 2.2× 374 0.6× 78 0.7× 72 0.8× 120 1.5× 45 2.4k
Taeyoung Koo South Korea 21 2.3k 2.5× 785 1.3× 161 1.4× 149 1.7× 58 0.7× 34 2.5k
Helena Costa Verdera France 7 917 1.0× 535 0.9× 219 1.8× 104 1.2× 43 0.5× 10 1.2k
Véronique Blouin France 22 1.0k 1.1× 993 1.6× 190 1.6× 115 1.3× 95 1.2× 37 1.3k
Jote Bulcha United States 3 733 0.8× 417 0.7× 172 1.4× 42 0.5× 38 0.5× 3 956
Kim Van Vliet United States 20 985 1.1× 987 1.6× 126 1.1× 180 2.0× 80 1.0× 23 1.3k
Simon Pacouret United States 10 490 0.5× 418 0.7× 109 0.9× 73 0.8× 25 0.3× 11 750
Tjadine M. Holling Netherlands 15 871 0.9× 203 0.3× 153 1.3× 95 1.1× 99 1.2× 20 1.5k
Guang Qu United States 12 892 1.0× 849 1.4× 198 1.7× 129 1.4× 88 1.1× 18 1.1k
Renee C. Ryals United States 19 1.4k 1.5× 549 0.9× 88 0.7× 62 0.7× 187 2.3× 36 1.7k

Countries citing papers authored by Melissa A. Kotterman

Since Specialization
Citations

This map shows the geographic impact of Melissa A. Kotterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Kotterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Kotterman more than expected).

Fields of papers citing papers by Melissa A. Kotterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa A. Kotterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Kotterman. The network helps show where Melissa A. Kotterman may publish in the future.

Co-authorship network of co-authors of Melissa A. Kotterman

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa A. Kotterman. A scholar is included among the top collaborators of Melissa A. Kotterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa A. Kotterman. Melissa A. Kotterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Croze, Roxanne H., et al.. (2021). Viral Vector Technologies and Strategies: Improving on Nature. International Ophthalmology Clinics. 61(3). 59–89. 4 indexed citations
2.
Kotterman, Melissa A., Roxanne H. Croze, Simon Tucker, et al.. (2021). Identification and Characterization of a Novel AAV Capsid and Product for the Treatment of Cystic Fibrosis. A1043–A1043. 1 indexed citations
3.
Kotterman, Melissa A., Kevin J. Whittlesey, Gabriel Brooks, et al.. (2019). P1516Novel cardiotropic AAV variant C102 vectors show superior gene delivery & reduced immunogenicity in non-human primates, transduction of human cardiomyocytes, & correction of Fabry disease phenotype. European Heart Journal. 40(Supplement_1). 3 indexed citations
4.
Kotterman, Melissa A., Thomas W. Chalberg, & David V. Schaffer. (2015). Viral Vectors for Gene Therapy: Translational and Clinical Outlook. Annual Review of Biomedical Engineering. 17(1). 63–89. 351 indexed citations breakdown →
5.
Kotterman, Melissa A. & David V. Schaffer. (2015). Engineered AAV vectors for improved central nervous system gene delivery. PubMed. 2(1). e1122700–e1122700. 9 indexed citations
6.
Kotterman, Melissa A., Tandis Vazin, & David V. Schaffer. (2015). Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant. Development. 142(10). 1885–1892. 27 indexed citations
7.
Kotterman, Melissa A. & David V. Schaffer. (2014). Engineering adeno-associated viruses for clinical gene therapy. Nature Reviews Genetics. 15(7). 445–451. 599 indexed citations breakdown →
8.
Kotterman, Melissa A., Lu Yin, Jennifer M. Strazzeri, et al.. (2014). Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Gene Therapy. 22(2). 116–126. 144 indexed citations
9.
Kotterman, Melissa A., et al.. (2014). Enhanced cellular secretion of AAV2 by expression of foreign viral envelope proteins. Biochemical Engineering Journal. 93. 108–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026